Atlas Trials

Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over

Clinical trial NCT00232947 · COMPLETED

Trial details

NCT number
NCT00232947
Sponsor
ID Biomedical Corporation, Quebec
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2005-10-01
Enrollment
900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.